VASCULAR ANOMALY
Clinical trials for VASCULAR ANOMALY explained in plain language.
Never miss a new study
Get alerted when new VASCULAR ANOMALY trials appear
Sign up with your email to follow new studies for VASCULAR ANOMALY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer drug shows promise for rare blood vessel disorders in kids and young adults
Disease control OngoingThis study tests the drug alpelisib (approved for breast cancer) in people aged 2 to 30 with certain genetic blood vessel growth disorders. Participants take the drug for at least 2 years and attend up to 16 clinic visits to check if their condition improves. The goal is to see i…
Matched conditions: VASCULAR ANOMALY
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 26, 2026 07:39 UTC
-
Could a melanoma drug tame rare blood vessel disorders?
Disease control OngoingThis study tests whether trametinib, a drug already approved for melanoma, can help people with rare blood vessel growth problems caused by a specific genetic pathway. About 45 children and young adults (ages 2 months to 30 years) will take the drug for up to 3 years. The goal is…
Matched conditions: VASCULAR ANOMALY
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
New imaging technique could shed light on lymphatic disorders
Diagnosis ENROLLING_BY_INVITATIONThis study uses a safe, near-infrared dye and a special camera to take pictures of the lymphatic system—the network that helps drain fluid from tissues. Researchers want to see how it works in healthy people and in those with conditions like lymphedema (swelling), lipedema, or va…
Matched conditions: VASCULAR ANOMALY
Sponsor: The University of Texas Health Science Center, Houston • Aim: Diagnosis
Last updated May 26, 2026 07:26 UTC